(Q48672918)

English

Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.

scientific article published in July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients. (English)

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

0 references

1 reference

based on heuristic

inferred from title

Calvin H Knowlton

8

object named as

Calvin H Knowlton

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

2

object named as

Kevin T Bain

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

Rollin Gallagher

6

object named as

Rollin M Gallagher

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

author name string

Douglas J Weschules

1

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

Joanne Reifsnyder

3

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

Jill A McMath

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

David E Kupperman

5

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

Walter W Hauck

7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

publication date

1 July 2006

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

7

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

4

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

320-329

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

A review of oxycodone's clinical pharmacokinetics and pharmacodynamics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Morphine and oxycodone hydrochloride in the management of cancer pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Morphine-6-glucuronide, a potent mu agonist.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Morphine-6-glucuronide has high affinity for the opioid receptor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Mu receptor binding of some commonly used opioids and their metabolites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Opioid hyperexcitability: the application of alternate opioid therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Morphine and alternative opioids in cancer pain: the EAPC recommendations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Controlled-release oxycodone and morphine in cancer related pain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Intravenous morphine and oxycodone for pain after abdominal surgery

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

A comparison of subcutaneous morphine and fentanyl in hospice cancer patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Safety and efficacy of controlled-release oxycodone: a systematic literature review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Methadone and the hospice patient: prescribing trends in the home-care setting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2006.00184.X

21 January 2018

Identifiers

10.1111/J.1526-4637.2006.00184.X

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

1 reference

Europe PubMed Central

14 February 2018

http://europepmc.org/abstract/MED/16898943

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48672918&oldid=1929950121"